{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:45:53Z","timestamp":1789926353340,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID 211086"],"award-info":[{"award-number":["ID 211086"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["IDs 358395"],"award-info":[{"award-number":["IDs 358395"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["571281"],"award-info":[{"award-number":["571281"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cerebral Circulation - Cognition and Behavior"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.cccb.2024.100372","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T22:51:04Z","timestamp":1733439064000},"page":"100372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-2869","authenticated-orcid":false,"given":"Katie","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"MacMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultana","family":"Shajahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Hamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.cccb.2024.100372_bib0001","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","article-title":"Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis","volume":"43","author":"Peters","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cccb.2024.100372_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet. Neurol."},{"issue":"19","key":"10.1016\/j.cccb.2024.100372_bib0003","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.cccb.2024.100372_bib0004","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jacc.2024.01.030","article-title":"Risk of dementia during antihypertensive drug therapy in the elderly","volume":"83","author":"Rea","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.cccb.2024.100372_bib0005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ageing\/afw155","article-title":"New horizons: the management of hypertension in people with dementia","volume":"45","author":"Harrison","year":"2016","journal-title":"Age. Age."},{"issue":"33","key":"10.1016\/j.cccb.2024.100372_bib0006","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/eurheartj\/ehy288","article-title":"Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension","volume":"39","author":"Abell","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cccb.2024.100372_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpae007","article-title":"Hypertension and mild cognitive impairment: state-of-the-art review","author":"Shajahan","year":"2024","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cccb.2024.100372_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100944","article-title":"Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies","volume":"55","author":"Xue","year":"2019","journal-title":"Age. Res. Rev."},{"key":"10.1016\/j.cccb.2024.100372_bib0009","doi-asserted-by":"crossref","unstructured":"Areosa Sastre, A., R.W. Vernooij, M. Gonzalez-Colaco Harmand, and G. Martinez, Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochran. Datab. Syst. Rev., 2017. 6(6): p. CD003804.","DOI":"10.1002\/14651858.CD003804.pub2"},{"issue":"3","key":"10.1016\/j.cccb.2024.100372_bib0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabet. Endocrinol."},{"issue":"8","key":"10.1016\/j.cccb.2024.100372_bib0011","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/dom.14391","article-title":"Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: results from the ADVANCE trial","volume":"23","author":"Gong","year":"2021","journal-title":"Diabet. Obes. Metab."},{"issue":"9590","key":"10.1016\/j.cccb.2024.100372_bib0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.cccb.2024.100372_bib0013","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cccb.2024.100372_bib0014","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00125-009-1484-7","article-title":"Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial","volume":"52","author":"de Galan","year":"2009","journal-title":"Diabetologia"},{"issue":"18","key":"10.1016\/j.cccb.2024.100372_bib0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cccb.2024.100372_bib0016","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cccb.2024.100372_bib0017","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2013.13656","article-title":"Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial","volume":"174","author":"Williamson","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"9","key":"10.1016\/j.cccb.2024.100372_bib0018","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"9287","key":"10.1016\/j.cccb.2024.100372_bib0019","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"MacMahon","year":"2001","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.cccb.2024.100372_bib0020","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: a Presidential Advisory From the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cccb.2024.100372_bib0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","article-title":"Cognitive Impairment in CKD: pathophysiology, Management, and Prevention","volume":"74","author":"Drew","year":"2019","journal-title":"Am. J. Kidn. Dis."},{"issue":"15","key":"10.1016\/j.cccb.2024.100372_bib0022","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.cccb.2024.100372_bib0023","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","article-title":"Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes","volume":"57","author":"Zoungas","year":"2014","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.cccb.2024.100372_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011104","article-title":"Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions","volume":"8","author":"Berry","year":"2019","journal-title":"J. Am. Heart. Assoc."},{"issue":"6","key":"10.1016\/j.cccb.2024.100372_bib0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cccb.2024.100372_bib0026","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.exger.2012.05.018","article-title":"Blood pressure, smoking and alcohol use, association with vascular dementia","volume":"47","author":"Peters","year":"2012","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.cccb.2024.100372_bib0027","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/FJC.0b013e3181d26469","article-title":"Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE","volume":"55","author":"Chalmers","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.cccb.2024.100372_bib0028","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/practneurol-2016-001520","article-title":"The Mini-Mental State Examination: pitfalls and limitations","volume":"17","author":"Devenney","year":"2017","journal-title":"Pract. Neurol."}],"container-title":["Cerebral Circulation - Cognition and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245024001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245024001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:20:31Z","timestamp":1749860431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666245024001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"alternative-id":["S2666245024001739"],"URL":"https:\/\/doi.org\/10.1016\/j.cccb.2024.100372","relation":{},"ISSN":["2666-2450"],"issn-type":[{"value":"2666-2450","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial","name":"articletitle","label":"Article Title"},{"value":"Cerebral Circulation - Cognition and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cccb.2024.100372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100372"}}